Kenneth Marek, MD

Institute for Neurodegenerative DisordersNew haven, Connecticut - 06510 (203 401 4362) |
- CLINICAL TRIALS 2
- CONDITIONS4
- INTERVENTIONS2
- SINCE2003

A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease
May 2003 - January 2013

Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects
May 2007 - December 2009
Depression
Depressive Disorder
Parkinson Disease
Parkinsonian Disorders
Automated Neuropsychological Assessment Matrix
123-I Mzint Injection And Spect Imaging



